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ABSTRACT Most current gene transfer methods function
satisfactorily in specialized systems involving established cell
lines but are often not applicable with nonadherent, primary
hematopoietic cells, which are notoriously difficult to transfect.
To approach this problem, we have investigated an alternative
method of gene transfer, "transferrnfection," in which DNA
complexed to transferrin-polycation conjugates is introduced
into cells by receptor-mediated endocytosis [Wagner, E.,
Zenke, M., Cotten, M., Beug, H. & Birnstiel, M. L. (1990)
Proc. Natl. Acad. Sci. USA 87, 3410-3414]. We show here that
transferrin-polylysine and transferrin-protamine, when com-
plexed to plasmid DNA containing a luciferase reporter gene,
is efficiently bound and moved into avian erythroblasts by
endocytosis. Successful transfer and expression of the Iu-
ciferase reporter gene depends on specific interaction of the
transferrin-polylysine-DNA complex with the transferrin re-
ceptor and occurs in a significant fraction (>95%) of the cells.
Gene transfer efficiency by transferrinfection is lower than
with an optimized DEAE-dextran transfection method but
reaches similar efficiencies when the cells are treated with
chloroquine. Because the procedure in the absence of chloro-
quine is completely nontoxic to cells, a constant expression level
of transferred genes may be maintained by repeated additions
of transferrin-polylysine-DNA complex. In addition, the use-
fulness of transferrinfection for gene transfer into primary
hematopoietic cells is demonstrated.
Many techniques are available to introduce and express
foreign DNA in eukaryotic cells (1-4). However, most pro-
cedures function well mainly with adherent cells and/or
established cell lines and are often associated with severe
cytotoxic side effects. In particular, most available methods
proved to be ineffective or too toxic with nonestablished
hematopoietic cells. Only recently, specific protocols em-
ploying electroporation or DEAE-dextran have met with
some success in such cells (5, 6). We have therefore studied
the utility of receptor-mediated endocytosis as an alternative
means to introduce and express DNA in hematopoietic cells,
thus avoiding cytotoxic effects. A similar approach has been
used by Wu and Wu (7) who employed the asialoglycoprotein
receptor to deliver DNA to liver cells.
In a recent communication (8) we have described trans-
ferrin-polycation conjugates that efficiently bind DNA of
widely different size and can replace native iron transferrin as
an efficient iron transporter into the living cell. Because
transferrin receptors are elevated on the surface of exten-
sively proliferating or neoplastic hematopoietic cells (for
review, see ref. 9), we attempted to use these transferrin-
polycation conjugates to efficiently introduce DNA into cells
via the transferrin cycle (a method termed "transferrinfec-
tion"). Pilot experiments described in the previous commu-
nication, showing the principal feasibility of the transferrin-
polylysine gene transfer approach (8), encouraged us to study
its usefulness with hematopoietic cells in more detail, by
using both established cell lines and primary hematopoietic
cells of avian origin.
MATERIALS AND METHODS
Transferrin-Polylysine and Transferrin-Protamine Conju-
gates and Recombinant Plasmids. The origin of polylysine
(Sigma), protamine (Sigma), and chicken transferrin (ion-
saturated conalbumin; Sigma) and the synthesis of transfer-
rin-polylysine and transferrin-protamine conjugates have
been described (8). The pRSVL plasmid DNA (10) as well as
the pRSV-,8Gal and pB-SK- DNAs (Stratagene) were pre-
pared by using the Triton-X lysis procedure (11) followed by
cesium chloride/ethidium bromide equilibrium density gra-
dient centrifugation, destaining with 1-butanol, and dialysis
against 10 mM Tris HCl, pH 7.5/1 mM EDTA.
Cells and Cell Culture. The temperature-sensitive v-
erbB-transformed chicken erythroblast cell line HD3 (12) as
well as the lymphoid (REVT) transformed clone REV NPB4
(13) were grown in standard growth medium (EBM + H; ref.
12) at a density of 1-2 x 106 cells per ml at 37°C and 5% Co2.
A primary clone of erythroblasts transformed by a retrovirus
expressing the human epidermal growth factor receptor to-
gether with a temperature-sensitive myb oncogene (EGFR-
ts-myb) was generated as will be described elsewhere (ref. 14
and H.B., unpublished work). The cells were grown in
CFU-E medium (15) in the presence of 20 ng of epidermal
growth factor per ml. Normal bone marrow cells were
prepared as described (16) and enriched for immature ery-
throid cells by centrifugation through Percoll at 1.072 g/cm3
and removal of cells adherent to plastic (17).
Transferrin-Polylysine-DNA or Transferrin-Protamine-
DNA Complex Formation and Gene Transfer Reaction. In a
typical complex formation reaction 10 ,g of transferrin-
polylysine or transferrin-protamine conjugate in 250 ,ul of
H20 was added to 3 ,tg of pRSVL plasmid DNA contained
in 250 ,lI of 0.3 M NaCl (added while agitating). Phosphate
buffers should be avoided because precipitates form. By
using the above conditions, up to 100 ,ug of transferrin-
polylysine or transferrin-protamine conjugate and 30 gg of
plasmid DNA could be used per 500 ,ul of final volume
without precipitation of the transferrin-polylysine-DNA or
transferrin-protamine-DNA complexes. After 30 min at
room temperature, the transferrin-polylysine-DNA or trans-
ferrin-protamine-DNA mixture was directly added to 5-10 x
106 HD3 cells growing at 0.5-1 x 106 cells per ml in standard
Abbreviation: FITC, fluorescein isothiocyanate.
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growth medium (see above) and incubated for 16-48 hr.
Other cell types were treated similarly, except being grown
in their respective media [see above; CFU-E medium plus
REV factor (13) was used for the normal bone marrow cells].
Preparation of Tritiated Transferrin-Polylysine. Tritiated
transferrin-polylysine was prepared by conjugation of triti-
ated polylysine to transferrin in a similar fashion as described
(8). Tritiation of poly(L-lysine) (hydrobromide salt, Mr
18,000; Sigma) was performed by treatment with formalde-
hyde and tritiated sodium borohydride (18).
Uptake of Transferrin-Polylysine-DNA Complexes into In-
tracellular Vesicles. Avian erythroblasts (HD3; ref. 12) were
incubated with transferrin-free differentiation medium (8) at
370C for 18 hr. After addition of transferrin-polylysine conju-
gates [labeled with fluorescein isothiocyanate (FITC) at the
polylysine moiety (8)] that had been complexed with DNA in
some of the experiments, cells were further incubated for 18
hr. Cells were cytocentrifuged onto slides, fixed with a mixture
of 3.7% formaldehyde (prepared from paraformaldehyde; ref.
19)/0.02% glutaraldehyde, washed with phosphate-buffered
saline (PBS), mounted in Mowiol 4.88 (Hoechst) (19), and
examined using a Zeiss Axiophot fluorescence microscope.
FITC-labeled goat antimouse antibody (0.1 mg/ml) was used
in the controls. For quantitative determination of FITC-
transferrin or FITC-transferrin-polylysine-DNA, cells were
incubated with the respective transferrin-polylysine prepara-
tion for 6 hr at 370C, washed three times in cold PBS/bovine
serum albumin, and processed for quantitative fluorescence
activated cell sorter analysis in a Becton Dickinson FACScan.
Luciferase Assay. Aliquots from cultures receiving trans-
ferrin-polylysine/transferrin-protamine-DNA complexes
were harvested by centrifugation (8 min, 1500 X g, 4°C), cell
extracts were prepared (10), and bioluminescence was mea-
sured with the Clinilumat counter LB 9502 (Berthold, Wild-
bach, F.R.G.). For determination of the percentage of cells
expressing DNA, the cells were allowed to take up transfer-
rin-polylysine-pRSV-,BGal complexes or, as controls, trans-
ferrin-polylysine-pB-SK- complexes prepared as above for
36 hr. Cells were then loaded with fluorescein di-p-D-galacto-
pyranoside (Molecular Probes) by osmotic shock, diluted in
staining medium, and processed in a Becton Dickinson
FACScan exactly as described (20).
RESULTS AND DISCUSSION
Efficient Binding and Internalization of Transferrin-
Polylysine-DNA Complexes in Avian Hematopoietic Cells.
Binding of transferrin-polylysine and transferrin-polylysine-
DNA to cell-surface receptors was measured with tritiated
compounds (21), whereas internalization was followed by
using fluoresceinated transferrin-polylysine. Fig. 1A shows
that both transferrin-polylysine and transferrin-polylysine-
DNA complexes bind to viable HD3 cells in a saturable
fashion. Apparent binding constants calculated from these
data were 22 nM for transferrin-polylysine and 43 nM for
transferrin-polylysine-DNA complexes. Although some-
what higher, these Kd values (which rather represent on-rates
than real dissociation constants; ref. 21) were still in reason-
able agreement with those determined for native transferrin
(15 nM; I. Killisch, P.S., K. Roemisch, H.B., and G. Griffith,
unpublished data).
To study internalization, transferrin-polylysine conjugates
containing a polylysine moiety labeled with fluorescein (8)
were complexed with DNA and added to HD3 cells (see
Materials and Methods). Numerous small fluorescent vesi-
cles were detected in >95% of the cells, in both the presence
and absence ofDNA (Fig. 2 B and C and data not shown). In
controls using either transferrin plus an unrelated fluorescent
antibody or fluorescent antibody alone, no fluorescent ves-
icles were observed (Fig. 2A and data not shown). These
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FIG. 1. Binding and internalization of transfemn-polylysine or
transferrin-polylysine-DNA by HD3 cells. (A) Tritiated transferrin-
polylysinego (r) or tritiated transferrin-polylysinego-DNA (A) were
assayed for specific binding to the transferrin receptor of HD3 cells,
as described. (B) HD3 cells were incubated with FITC-transferrin at
40 ,ug/ml (-e-), FITC-transferrin-polylysine270 at 50 ,Lg/ml (-),
FITC-transferrin-polylysine270 plus pB-SK- DNA at 50 ,ug/ml and
16 jig/ml, respectively (->e), and binding buffer (.) for 6 hr and
processed for fluorescence-activated cell sorter analysis as de-
scribed.
observations were confirmed by FACSCAN analysis ofHD3
cells allowed to internalize FITC-transferrin-polylysine or
transferrin-polylysine-DNA for 6 hr. With both transferrin-
polylysine and transferrin-polylysine-DNA, essentially all
cells showed >10-fold increase in relative fluorescence in-
tensity (Fig. 1B), indicating that the transferrin-polylysine-
DNA complexes are internalized by >95% of the cells.
Optimized Procedure for Transferrinfection of Avian Eryth-
roblasts. To establish an optimal ratio of transferrin-
polylysine or transferrin-protamine versus DNA in the com-
plex formation reaction a constant amount of transferrin-
polylysine or transferrin-protamine conjugate (10 pug) was
mixed with an increasing amount of luciferase-encoding
plasmid DNA (0.1-10 ,ug ofpRSVL) and incubated with HD3
cells; the cells were analyzed for the luciferase enzyme
activity produced. Fig. 3A shows that maximal luciferase
enzyme activity was achieved when 3 ,ug of DNA per 10 ,ug
of transferrin-polylysine and 0.3-1 ug of DNA per 10 ,ug of
transferrin-protamine conjugate were used. By assuming
that all the transferrin-polylysine-DNA or transferrin-
protamine-DNA complexes formed were identical, this rep-
resents a molar ratio of 25 transferrin-polylysine molecules
(or 75 transferrin-protamine molecules, respectively) per
molecule of plasmid DNA. It appears, therefore, that in this
complex the DNA is completely covered by transferrin-
polylysine or transferrin-protamine molecules at a transfer-
A B
FIG. 2. Uptake of transferrin-polylysine into intracellular vesi-
cles. Viable HD3 cells were incubated with FITC-transferrin-
polylysine270 (B) or, as a control, with FITC-labeled goat anti-mouse
IgG (A) for 18 hr, cytocentrifuged onto slides, and processed for
fluorescence microscopy as described. (C) The same field as in B
viewed under conditions for tetramethylrhodamine (TRITC)-
fluorescence to rule out nonspecific vesicle fluorescence due to
fixation (H.B., unpublished work).
B
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FIG. 3. Optimal conditions for complex formation and sensitivity of transferrinfection. (A) For complex formation 0-10 gg of luciferase-
encoding plasmid DNA (pRSVL; ref. 10) were mixed with 10 ,Ag of transferrin-polylysine270 (x) or transferrin-protamine conjugates (0),
respectively, and used for transferrinfection of HD3 cells. Cell lysates were then assayed for luciferase enzyme activity (8) and expressed as
light units per 107 cells. (B) With an optimized transferrin-polycation/DNA ratio in the complex formation reaction (3 ,ug of transferrin-
polylysine270 conjugate or 10 Ag of transferrin-protamine conjugate per 1 Ag of pRSVL DNA, respectively) 1 ng-10 /Ig of pRSVL DNA were
transferrinfected to 107 HD3 cells. After 24 hr extracts were analyzed for luciferase activity as in A.
rin-polylysine/DNA or transferrin-protamine/DNA ratio
that probably results in electroneutrality.
With such an optimized transferrin-polylysine/DNA or
transferrin-protamine/DNA ratio for complex formation we
have determined the sensitivity of this gene transfer system
by altering the amounts of transferrin-polylysine-DNA com-
plex added. Less than 1 ng of luciferase-encoding plasmid
DNA per 5 x 106 HD3 cells still yielded a detectable signal
(Fig. 3B). Apparent saturation of the system was obtained at
2 ,ug of plasmid DNA complexed with 6 ,g of transferrin-
polylysine or 20 ,ug of transferrin-protamine conjugate, re-
spectively; higher doses failed to further increase the lu-
ciferase activity measured (Fig. 3B).
Dependence of Gene Transfer by the Transferrin-Polyly-
sine-DNA (and Transferrin-Protamine-DNA) Complexes on
Specific Interaction with the Transferrin Receptor. Next we
studied whether and to what extent uptake of the transferrin-
polycation-DNA complexes into cells occurred by means of
specific, receptor-mediated endocytosis. For this analysis,
two approaches were used (Fig. 4A and data not shown).
First, luciferase activities obtained by using polylysine-DNA
complexes were close to the background activity of the
assay. Similarly, mixtures of polylysine and native transfer-
DNA
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DNA+pL+Tf
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863
rin with DNA did not lead to luciferase gene expression
significantly above background. It appears therefore that
transferrinfection is dependent on a covalent complex ofboth
transferrin and polylysine.
In the second type of experiment an excess of native, free
transferrin was added to a constant amount of transferrin-
polylysine-DNA complexes to compete for transferrin bind-
ing to its cognate receptor. Fig. 4A shows that free transferrin
in the medium efficiently competed for the transferrin-
polylysine-mediated DNA uptake, as witnessed by a 95%
reduction of luciferase enzyme activity. Therefore, we con-
clude that transfer of the transferrin-polylysine-DNA com-
plexes into cells depends on the transferrin receptor. This
notion is further confirmed by experiments in which the
abundance of transferrin receptors on the surface of HD3
cells and a human leukemia cell line has been modulated by
various means, leading to the expected changes in transfer-
rin-polylysine-mediated gene transfer efficiency (data not
shown and ref. 22).
To study which fraction of the cells actually express
plasmid DNA administered by transferrin-polylysine, HD3
cells were incubated with transferrin-polylysine-pRSV-/3Gal
complexes. Expression of this reporter gene was then studied
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FIG. 4. Uptake oftransferrin-polylysine-DNA complexes occurs via the transferrin receptor. (A) Three micrograms ofpRSVL DNA without
polycations (DNA), plus 2 ;tg of polylysine270 (DNA + pL), plus 2 ;tg of polylysine270 and 10 j&g of iron-saturated transferrin (Tf) (DNA + pL
+ Tf), or plus 10 ,ug of transferrin-polylysine270 conjugate (DNA + TfpL) were mixed in typical complex formation reactions. After
transferrinfection to 107 HD3 cells, cell extracts were prepared and analyzed for luciferase activity. Transferrinfection of transferrin-
polylysine-DNA complexes (DNA + TfpL) was performed in the absence of exogenous transferrin (no Tf*) and in the presence of exogenous
free transferrin at 1, 10, 100, and 1000 ng/ml in the culture medium (1 ng-1000 ng/ml Tf*). Average values of three independent experiments
(the values of DNA, DNA + pL, and DNA + pL + Tf are given in numbers) are shown. (B) HD3 cells were transferrinfected in absence of
chloroquine with transferrin-polylysine-pRSV-I3Gal (-) or, as a control, by transferrin-polylysine-pB-SK (---) and analyzed forB
galactosidase expression by fluorescence-activated cell sorter analysis.
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FIG. 5. Chloroquine enhances the efficiency of transferrinfection. (A) Three micrograms of pRSVL DNA was transfected to 2 x 107 HD3
cells without and with 20, 60, and 200 ,uM chloroquine using a DEAE-dextran protocol optimized for chicken hematopoietic cells (ref. 6; o).
Similarly, 3 ,g of pRSVL DNA complexed with 10 jig of transferrin-polylysine270 conjugate were transferrinfected to the same number ofHD3
cells in the absence and presence of chloroquine (e). Twenty-four hours later cell extracts were analyzed for luciferase enzyme activity (the
values for 106 cells are shown). (B) Transferrinfection of 3 ,g of pRSVL DNA (complexed with 10 ,g of transferrin-polylysine270 conjugate)
to 2 x 107 HD3 cells was performed both in the absence (0 hr) and presence of chloroquine (200 ,uM). After 2, 4, 6, and 8 hr of transferrinfection
in the presence of chloroquine, cells were extensively washed, seeded in fresh growth medium and incubated for a total of 24 hr. In addition,
cells were treated with chloroquine (200 AiM) for the entire transferrinfection period (24 hr). Luciferase activity was determined as described
for A.
at the single-cell level by FACS analysis (20) after introducing
the f-galactosidase substrate fluorescein di-p3-D-galactopy-
ranoside. The unimodal distribution of cells containing fluo-
rescein derived from fluorescein di-f3-D-galactopyranoside
due to ,B-galactosidase enzyme activity suggests that a large
fraction of the cells exhibited expression of the P-galacto-
sidase reporter gene (Fig. 4B).
Chloroquine Augments the Efficiency of Transferrin-
Polylysine-Mediated Gene Transfer. To obtain information on
the efficiency of the transferrin-polylysine-mediated gene
transfer as compared with conventional methods, we intro-
duced the pRSVL plasmid into HD3 cells by DEAE-dextran
transfection, using a protocol optimized for avian erythroid
cells (6). In comparison with this method, transferrinfection
was consistently found to be 50- to 100-fold less efficient (Fig.
5A). It should be noted, however, that the DEAE-dextran
protocol was quite toxic, always killing 30-40% of the
transfected cells, whereas no cytotoxic effects were observed
using the transferrin-polylysine method.
To test whether the relatively low efficiency of DNA
transfer by transferrin-polylysine or transferrin-protamine
conjugates could be due to trapping and/or degradation ofthe
DNA within the endosomal/lysosomal pathway, chloro-
quine, a drug known to alter lysosomal pH and thus to inhibit
lysosomal degradation of macromolecules (23), was added to
cells simultaneously with the transferrin-polylysine-DNA
complexes. With this treatment, the gene transfer efficiency
(as measured by luciferase activity) was highly elevated and
approached levels similar to those seen for DEAE-dextran
transfection, which by itself could not be further increased by
chloroquine (Fig. SA). The disadvantage of the chloroquine
procedure, however, was the appearance of a cytotoxic
effect, especially at prolonged exposure of the cells and at
high concentrations ofchloroquine. We therefore tried to add
the chloroquine in a pulsed fashion, which largely avoided
cytotoxicity. By using increasingly shorter times of incuba-
tion with chloroquine we found that its application for 3-4 hr
was sufficient for maximum gene transfer activity (Fig. SB).
Transient Expression ofDNA After Transferrin-Polylysine-
Mediated Gene Transfer. Because the transferrin-polylysine
gene transfer method was not deleterious to cell proliferation,
the effect of transferrin-polylysine-DNA complexes applied
to cells over an extended period of time was tested. In this
experiment, the same concentration of cells (1 x 106 cells per
ml) were incubated for 1-4 days with or without daily
readdition of transferrin-polylysine-DNA complexes. At
various time periods, aliquots were analyzed for luciferase
enzyme activity. In the cultures with repeated administration
of transferrin-polylysine-DNA complexes, a relatively high
level of luciferase gene expression (100,000-200,000 light
units per 107 cells) was seen in the absence of chloroquine,
which remained essentially constant over the period of in-
vestigation (data not shown). No cytotoxic effects were
observed during this time. In contrast, when cells were
loaded with transferrin-polylysine-DNA complexes only
once for 24 hr, the luciferase activity declined 10- to 20-fold
between day 2 and day 4 (data not shown). These results
suggest that although expression of the luciferase gene in-
troduced into cells by the transferrin-polylysine method is
transient, a constant high expression of transferred genes can
be maintained by repeated addition of transferrin-polyly-
sine-DNA complex, a feature not offered by the other known
DNA-transfer methods.
Transferrinfection of Primary Avian Hematopoietic Cells.
To test the suitability of transferrinfection for gene transfer
into primary avian cells, EGFR-ts-myb erythroblasts, REVT
transformed lymphoblasts, and erythroid cells enriched from
normal bone marrow were subjected to transferrinfection
with transferrin-polylysine-pRSVL complexes. In primary
erythroblasts, gene transfer by the transfemn-polylysine
method was -30- to 50-fold less effective as in HD3 cells
(Table 1). However, the efficiency of DEAE-dextran trans-
fection was reduced in these cells to a similar degree (data not
shown). Expression of the pRSVL plasmid DNA was not
restricted to the erythroid lineage because it was also ob-
served in transformed lymphoid cells (REV NPB4, Table 1).
In freshly prepared, normal bone-marrow cells, low but
significant luciferase activity was seen after transferrin-
polylysine-mediated gene transfer (Table 1), possibly due to
a large proportion of noncycling, transferrin-receptor nega-
tive cells in this preparation (24). Our results demonstrate
that transferrinfection can be applied for gene transfer into
primary cells, even without prior cultivation in vitro.
With the conditions used so far for transferrinfection,
expression of the DNA introduced is transient. However,
Table 1. Transferrinfection of primary hematopoietic cells
pRSVLuc expression, light
Cell type units/10 x 106 cells
HD3 ebl 5 x 105
EGFR-myb-ebl 1.4 x 104
REV-NPB4 lymphoblasts 1.7 x 105
Normal bone-marrow cells 6.6 x 103, 7.8 x l03
The various cell types were transferrinfected in the absence of
chloroquine. ebl, Erythroblast.
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even when using a vast excess of transferrin-polylysine-
DNA or transferrin-protamine-DNA complexes (10-fold
above the physiological concentration of native transferrin),
no cytotoxic effects of the compounds have been observed,
thereby enabling their repeated administration both at high
concentration and over an extended period of time.
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